These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36494048)

  • 41. Microglia mediated neuroinflammation in autism spectrum disorder.
    Liao X; Yang J; Wang H; Li Y
    J Psychiatr Res; 2020 Nov; 130():167-176. PubMed ID: 32823050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder.
    Xiong Y; Chen J; Li Y
    Front Neurosci; 2023; 17():1125428. PubMed ID: 37021129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders.
    Beversdorf DQ; Stevens HE; Jones KL
    Curr Psychiatry Rep; 2018 Aug; 20(9):76. PubMed ID: 30094645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways.
    Moradi K; Ashraf-Ganjouei A; Tavolinejad H; Bagheri S; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110091. PubMed ID: 32891667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of immune dysfunction in the pathophysiology of autism.
    Onore C; Careaga M; Ashwood P
    Brain Behav Immun; 2012 Mar; 26(3):383-92. PubMed ID: 21906670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder.
    Vuong HE; Hsiao EY
    Biol Psychiatry; 2017 Mar; 81(5):411-423. PubMed ID: 27773355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
    Gładysz D; Krzywdzińska A; Hozyasz KK
    Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmortem Studies of Neuroinflammation in Autism Spectrum Disorder: a Systematic Review.
    Liao X; Liu Y; Fu X; Li Y
    Mol Neurobiol; 2020 Aug; 57(8):3424-3438. PubMed ID: 32529489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocannabinoid System Unlocks the Puzzle of Autism Treatment
    Su T; Yan Y; Li Q; Ye J; Pei L
    Front Psychiatry; 2021; 12():734837. PubMed ID: 34744824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish.
    Pensado-López A; Veiga-Rúa S; Carracedo Á; Allegue C; Sánchez L
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function.
    Li YJ; Zhang X; Li YM
    CNS Spectr; 2020 Aug; 25(4):493-501. PubMed ID: 31659946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of Microglia on Neurodevelopment and Brain Function in Autism.
    Luo Y; Wang Z
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity.
    Sarn N; Thacker S; Lee H; Eng C
    Mol Autism; 2021 Jun; 12(1):41. PubMed ID: 34088332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling Autism-Related Disorders in Mice with Maternal Immune Activation (MIA).
    Lammert CR; Lukens JR
    Methods Mol Biol; 2019; 1960():227-236. PubMed ID: 30798536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding autism spectrum disorders with animal models: applications, insights, and perspectives.
    Li Z; Zhu YX; Gu LJ; Cheng Y
    Zool Res; 2021 Nov; 42(6):800-824. PubMed ID: 34755500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of glucose 6-phosphate dehydrogenase (G6PD) deficiency and its association to Autism Spectrum Disorders.
    Mondal A; Mukherjee S; Dar W; Singh S; Pati S
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166185. PubMed ID: 34087423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.